Sentence examples for analysis for superiority from inspiring English sources

The primary efficacy analysis for superiority of budesonide MMX 9 mg or 6 mg versus placebo was based on a χ test at a two-sided significance level of α=0.025.

9 10 The recommended primary analysis population for superiority trials is defined by the intention to treat principle, whereby data from all trial participants are analysed according to their randomly allocated study arm, irrespective of the degree of compliance or crossover to other interventions.

This sample size also allows for an analysis of superiority of the efficacy of the two test dose arms to placebo.

16) Statistical analysis a) Primary analysis for trials on superiority of acupuncture should be intention-to-treat.

If the studies were too heterogeneous to warrant a meta-analysis; then the evidence for superiority,non-inferiority or equivalence would be assessed for consistency across the studies.

While no benefit for lapatinib was recorded among HER-2-negative tumors on an intention-to-treat basis, a pre-defined analysis revealed superiority for lapatinib in a subgroup of HER-2 non-amplified tumors with an early relapse on tamoxifen.

For superiority trials, ITT analysis is the preferred analysis as it adheres to randomization [11] and might best reflect clinical practice.

This result was supported by the AUC analysis showing a strong trend for superiority of CTP over MELD scores (AUROC 0.73 and 0.68, resp.; p = 0.091).

Although the intention-to-treat (ITT) analysis is the preferred approach for superiority trials, its role in non-inferiority trials is still under debate.

Both studies were stopped at the first preplanned interim analysis for benefit and demonstrated superiority of RD compared with single-agent dexamethasone in terms of response rates, time to progression, and overall survival (OS).

The Kruskal-Wallis non-parametric test for multiple comparison analysis demonstrated superiority of the Antp-p21/cisplatin/taxol treatment group versus all the other treatment groups (p = 0.045).